Italia markets open in 4 hours 27 minutes

Dow Jones
39.872,99
+66,22(+0,17%)
Nasdaq
16.832,62
+37,75(+0,22%)
Nikkei 225
38.692,43
-254,50(-0,65%)
EUR/USD
1,0864
+0,0005(+0,04%)
Bitcoin EUR
64.619,82
-813,07(-1,24%)
CMC Crypto 200
1.527,02
+38,47(+2,59%)

NVCR Jan 2025 22.500 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

5,42

0,00

(0,00%)

In data: 11:17AM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in